# Final Forensic Audit — Post E24

Status: COMPLETE — RELEASE GATE PASSED

Audit date: 2026-10-03
Repository: LloydCoder/hezqara
Final implementation head before audit: c0d8e40c80976b3e6450d050d2a72864487835aa

## Scope

A final repository-level forensic review was performed after E24 covering the phase sequence, migrations, tenant/RLS surfaces, API registration, AI governance/tool boundaries, healthcare workflows, interoperability metadata, security/compliance evidence, reliability/DR contracts, commercial/launch gates, documentation and GitHub state.

## Verified findings

- E1–E8 and post-E8 foundation were already established as verified engineering controls.
- E9–E24 are implemented and merged to main in serial order.
- E16–E24 database migrations are included in the canonical CI migration sweep.
- E17, E18, E20, E21, E22, E23 and E24 have explicit database/RLS proof steps in canonical CI.
- Backend compile/import, Ruff, pytest and security test suites are green on the E24 implementation head.
- Frontend lint, type-check and production build are green on the E24 implementation head.
- Playwright E2E is green on the E24 implementation head.
- Docker backend and frontend image builds are green on the E24 implementation head.
- HEZQARA Security is green on the E24 implementation head.
- E8 Production Proving is green on the E24 implementation head.
- The Phases 9–16 validation workflow is green; later phases are additionally covered by canonical CI database/backend/frontend/security gates.
- Open PRs: 0.
- Open issues: 0.
- Repository search found no unfinished TODO, FIXME, NotImplementedError, or known demo-tenant placeholders in the enforced source-hygiene scope.
- README and phase documentation were reconciled so E24 is no longer described as an unfinished implementation phase.

## Architectural audit conclusions

1. MCP is an interface and is not treated as an authorization boundary.
2. AI output remains untrusted data; consequential actions remain governed by policy/approval controls.
3. Ambient documentation remains draft material until clinician review/edit/approval.
4. Clinical triage, symptom checking, autonomous diagnosis, treatment recommendation and autonomous clinical decision-making remain outside the launch boundary.
5. Provider secrets remain outside integration metadata and belong in the deployment secret manager.
6. Tenant isolation is enforced at the application and PostgreSQL RLS layers for the new E16–E24 surfaces.
7. E24 launch gates explicitly remain evidence-driven rather than assuming readiness from code presence.

## External prerequisites that are not code defects

The repository cannot truthfully self-certify:

- HIPAA/GDPR/NDPA or other legal/regulatory certification
- BAAs/DPAs and vendor contractual execution
- independent penetration-test results
- live EHR/payer/payment provider contracts and production credentials
- clinical efficacy or clinician adoption
- real production scale/SLO attainment beyond automated engineering evidence
- customer ROI or commercial validation

Those remain external release prerequisites and must be completed before making corresponding public claims.

## Vercel production gate

The Vercel production deployment gate is now unlocked from the engineering-phase perspective because E24 and the final repository audit are complete and the required automated workflows are green. Production deployment must still use the documented production secrets/configuration and must not be interpreted as regulatory certification.

## Final release rule

No unresolved repository blocker remains in the audited scope. Any future change that affects a verified phase reopens that phase's evidence gate and must restore green CI/security/E2E evidence before release.
